Objective: To examine the effects of topically applied recombinant human insulin-like growth factor 1 (IGF1) via gelatin hydrogels on alterations in pure-tone audiometry (PTA) in patients with sudden sensorineural hearing loss (SSHL) refractory to systemic steroids.
INTRODUCTION

Results
Alterations in PTA thresholds
shows alterations in mean PTA hearing levels between at registration and 24 weeks after treatment for each patient. The mean PTA hearing level at registration was 81.2 dB (95% confidence interval [CI] , 71.2-91.1) and that of 24 weeks after treatment was 69.3 dB (95% CI, 59.8-78.7). The time course of alterations in averages of PTA thresholds is shown in Figure 2A and was statistically significant (P < 0.001). Figure   2B -F shows the time courses of alterations in PTA thresholds at frequencies of 0.25, 0.5, 1, 2 and 4 kHz, which were all found to be statistically significant (P < 0.001). These findings indicate that topical IGF1 treatment via gelatin hydrogels has significant effects on the recovery of PTA thresholds in patients with SSHL refractory to systemic steroids.
Difference in PTA recovery among frequencies
The mean recovery for the average PTA threshold of five frequencies tested 24 weeks after treatment was 11.9 dB (95% CI, 5.8-17.9), and means of recoveries in PTA thresholds for each frequency are shown in Figure 3 . Differences in the recovery of PTA thresholds among frequencies were statistically significant (P = 0.0003), and we observed a trend that hearing recovery at 2 or 4 kHz was smaller than at lower frequencies. These findings indicate that PTA hearing recovery following topical IGF1 treatment predominantly occurred at low frequencies. (Fig. 3B-F) . At 4 weeks, 20-dB recovery appeared in 7/11 patients (64%) at 0.25 kHz, 11/13 (85%) at 0.5 kHz, 7/10 (70%) at 1 kHz, 3/6 (50%) at 2 kHz and 5/6 (83%) at 4 kHz. These findings demonstrate that PTA hearing recovery after topical IGF1 treatment occurred during the initial four weeks in the majority of patients, but that further recovery was evident in some patients at a later stage.
Time-points for hearing recovery
Comparison with a historical control
The recoveries of PTA thresholds for each frequency tested and for the average of five frequencies 24 weeks after topical IGF1 treatment were compared with those in a historical control of hyperbaric oxygen therapy (Fig. 3) . The recovery of the average PTA thresholds after topical IGF1 treatment was larger than that of a historical controls (11.9 ± 2.9 [mean ± standard error] for IGF1 v.s. 8.0 ± 0.9 for historical control), but the difference was not statistically significant (P = 0.08). For each frequency, there is a trend that topical IGF1 treatment shows better PTA threshold recoveries than a historical control (Fig. 3) . The difference in PTA threshold recoveries at 1 kHz between the two group was statistically significant at P = 0.04, while at other frequencies no 
